These findings imply that SHCBP1 facilitates immune escape via FGFR-dependent enhancement of α-smooth muscle actin positive cancer–associated fibroblast (CAF) infiltration and suppression of cytotoxic T cell infiltration. The gene discussed is SHCBP1; the disease is cancer.